| Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis (NCT07047339) | Changhai Hospital | 2025-07-01 |
| Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23) (NCT07032532) | Sun Yat-sen University | 2025-07-01 |
| Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) (NCT07185841) | Fujian Haixi Pharmaceuticals Co., Ltd. | 2025-07-01 |
| Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy (NCT04480450) | University of Kansas Medical Center | 2025-07-01 |
| PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment (NCT07028424) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2025-07-01 |
| Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. (NCT07025980) | Eva Cubric | 2025-07-01 |
| A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients (NCT07073677) | HK inno.N Corporation | 2025-07-01 |
| Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote (NCT07032142) | D'Or Institute for Research and Education | 2025-07-01 |
| Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy (NCT07028528) | RDC Clinical Pty Ltd | 2025-07-01 |
| Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair (NCT05505747) | Austin V Stone | 2025-07-01 |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults (NCT06937931) | Ipsen | 2025-06-30 |
| Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol (NCT07028749) | Marea Therapeutics | 2025-06-30 |
| A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis (NCT07103174) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-06-30 |
| A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC. (NCT06982924) | Shanghai Chest Hospital | 2025-06-30 |
| Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options (NCT06794554) | Mundipharma Research Limited | 2025-06-30 |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy (NCT06979375) | Novo Nordisk A/S | 2025-06-30 |
| Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer (NCT07005583) | Tianjin Medical University Cancer Institute and Hospital | 2025-06-30 |
| Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype (NCT06486883) | MedSIR | 2025-06-30 |
| Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) (NCT06773026) | Jerry Vockley, MD, PhD | 2025-06-30 |
| Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors (NCT06835387) | Tiago Biachi de Castria | 2025-06-30 |
| GV101 in Healthy Obese Participants (NCT06979505) | Graviton Bioscience Corporation | 2025-06-30 |
| Use of PRP in Open Surgery for Type A Aortic Dissection (NCT07005661) | Beijing Anzhen Hospital | 2025-06-30 |
| Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome (NCT07043322) | Tanta University | 2025-06-30 |
| A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy (NCT07029139) | Shanghai JMT-Bio Inc. | 2025-06-30 |
| Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old (NCT07049159) | Eveliqure Biotechnologies GmbH | 2025-06-30 |
| Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) (NCT07509749) | Daihong Liu | 2025-06-30 |
| Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy (NCT06767956) | University of Pittsburgh | 2025-06-30 |
| Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity (NCT06979531) | Immunovant Sciences GmbH | 2025-06-30 |
| A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT06839872) | AstraZeneca | 2025-06-30 |
| A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44 (NCT07037862) | Entrada Therapeutics, Inc. | 2025-06-30 |
| A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations (NCT06892522) | AbbVie | 2025-06-30 |
| A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer (NCT07031154) | The First Affiliated Hospital of Xiamen University | 2025-06-30 |
| A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC (NCT06962865) | RemeGen Co., Ltd. | 2025-06-30 |
| Open-Label Extension Protocol to SNK01-AD01 Study (NCT07228078) | NKGen Biotech, Inc. | 2025-06-30 |
| A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy (NCT07053761) | Peking University First Hospital | 2025-06-30 |
| Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST) (NCT07045909) | PETHEMA Foundation | 2025-06-30 |
| A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors (NCT06873789) | Incyte Corporation | 2025-06-30 |
| A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) (NCT06009107) | Juventas Cell Therapy Ltd. | 2025-06-30 |
| A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors (NCT07003139) | China Medical University Hospital | 2025-06-30 |
| Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study (NCT06471556) | Assistance Publique - Hôpitaux de Paris | 2025-06-30 |
| A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer (NCT07770113) | The First Affiliated Hospital of Zhengzhou University | 2025-06-30 |
| The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease (NCT07028632) | iRegene Therapeutics Co., Ltd. | 2025-06-30 |
| Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy (NCT06840834) | Intergroupe Francophone de Cancerologie Thoracique | 2025-06-30 |
| Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury (NCT07016074) | University of Michigan | 2025-06-30 |
| A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) (NCT07043946) | Climb Bio, Inc. | 2025-06-30 |
| Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer (NCT07019337) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-06-30 |
| Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer (NCT07059949) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2025-06-30 |
| Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer (NCT07041437) | Fudan University | 2025-06-30 |
| A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH) (NCT06643143) | Inhibikase Therapeutics | 2025-06-30 |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer (NCT06966453) | Pfizer | 2025-06-30 |
| Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy (NCT07012304) | Yujun DONG | 2025-06-30 |
| Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation (NCT07034950) | The First Affiliated Hospital of Xiamen University | 2025-06-29 |
| Regenerative Endodontic Treatment Using Sodium Hexametaphosphate (SHMP) For Necrotic Immature Permanent Anterior Teeth (NCT07097688) | Ahmad Elheeny | 2025-06-29 |
| Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts (NCT06809777) | Sheikh Zayed Medical College | 2025-06-29 |
| Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial (NCT07003620) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-06-29 |
| Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells (NCT07041801) | Shenzhen Beike Bio-Technology Co., Ltd. | 2025-06-28 |
| A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients. (NCT07040956) | West China Hospital | 2025-06-28 |
| SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies (NCT07153068) | Institute of Hematology & Blood Diseases Hospital, China | 2025-06-28 |
| Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis (NCT06960694) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2025-06-28 |
| Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma (NCT07169383) | Hina Malik | 2025-06-28 |
| Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis (NCT07079423) | Peking Union Medical College Hospital | 2025-06-28 |
| Study of CM518D1 in Patients With Advanced Solid Tumors (NCT07019779) | Keymed Biosciences Co.Ltd | 2025-06-27 |
| Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study (NCT07001800) | Kardigan, Inc. | 2025-06-27 |
| Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06995677) | Tyra Biosciences, Inc | 2025-06-27 |
| PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) (NCT06665100) | Pulmotect, Inc. | 2025-06-27 |
| QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC (NCT07009145) | Qianfoshan Hospital | 2025-06-27 |
| REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis (NCT06315010) | MedSIR | 2025-06-27 |
| A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function (NCT06993155) | ReproNovo Aps | 2025-06-27 |
| Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants (NCT07254000) | Monash Medical Centre | 2025-06-27 |
| Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT07019090) | Haisco Pharmaceutical Group Co., Ltd. | 2025-06-27 |
| Prospective Single-Arm Clinical Trial of GO Regimen for HLH. (NCT07339345) | Beijing Friendship Hospital | 2025-06-27 |
| M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis (NCT06907680) | RDC Clinical Pty Ltd | 2025-06-27 |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy (NCT06979362) | Novo Nordisk A/S | 2025-06-27 |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia (NCT07038876) | MapLight Therapeutics | 2025-06-27 |
| A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (NCT07082738) | AstraZeneca | 2025-06-27 |
| Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors (NCT07040969) | West China Hospital | 2025-06-27 |
| Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) (NCT06826859) | Thomas Jefferson University | 2025-06-26 |
| Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care (NCT07034963) | The First Affiliated Hospital of Xiamen University | 2025-06-26 |
| To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII. (NCT07055243) | University Health Network, Toronto | 2025-06-26 |
| Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study (NCT06350630) | Centre Hospitalier Universitaire de Saint Etienne | 2025-06-26 |
| Hypofractionated Radiochemotherapy (NCT06331468) | Denise Fabian | 2025-06-26 |
| Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension (NCT06992440) | Gustavo A Heresi, MD, MS | 2025-06-26 |
| A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease (NCT07113522) | Mirador Therapeutics, Inc. | 2025-06-26 |
| PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML (NCT06409936) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2025-06-26 |
| A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults (NCT06803342) | Albert B. Sabin Vaccine Institute | 2025-06-26 |
| An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. (NCT07033026) | NGM Biopharmaceuticals, Inc | 2025-06-25 |
| A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) (NCT07035626) | West China Hospital | 2025-06-25 |
| A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC (NCT06984718) | Akeso | 2025-06-25 |
| A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC (NCT06951464) | Sichuan University | 2025-06-25 |
| Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck (NCT06990737) | University of California, Davis | 2025-06-25 |
| Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma (NCT06861452) | EIR Biotherapies s.r.l. | 2025-06-25 |
| Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer (NCT07285382) | wanghaibo | 2025-06-25 |
| Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib (NCT07033819) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-06-25 |
| Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001 (NCT07264569) | Henan Cancer Hospital | 2025-06-25 |
| Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma (NCT06673693) | Sun Yat-sen University | 2025-06-25 |
| Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors (NCT06819735) | Domain Therapeutics Australia Pty Ltd | 2025-06-25 |
| A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD (NCT06843408) | Incyte Corporation | 2025-06-25 |
| Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer (NCT06976944) | Yukinori Ozaki | 2025-06-24 |
| A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma (NCT06986785) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-06-24 |
| Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. (NCT07048808) | XyloCor Therapeutics, Inc. | 2025-06-24 |